<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Postmenopausal bleeding — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Postmenopausal bleeding</h1>
        <div class="sub">Evidence summary (key statements + how they fit together) → DGRefHelp first draft (D&amp;G). Includes required referral-letter info.</div>
      </div>
      <div class="badges">
        <div class="badge">Mode: quick</div>
        <div class="badge">Last updated: 2026‑02‑11</div>
      </div>
    </div>

    <div class="grid">
      <div class="card">
        <div class="card-hd">
          <div class="tabs" data-tabs>
            <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence</button>
            <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
            <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
          </div>
          <div class="copybar">
            <button class="btn" data-copy-target="#draftText">Copy draft</button>
            <button class="btn" data-copy-target="#evidenceText">Copy evidence</button>
          </div>
        </div>

        <div class="card-bd">
          <div class="panel active" role="tabpanel" data-panel="evidence">
            <div id="evidenceText" class="section">
              <h3>Evidence summary (triangulated)</h3>

              <div class="callout">
                <strong>Related pages</strong>
                <div class="small">
                  <ul>
                    <li><a href="./bleeding-on-hrt.html">Bleeding on HRT</a> (unscheduled bleeding in people using HRT).</li>
                    <li><a href="./abnormal-uterine-bleeding.html">Abnormal uterine bleeding</a> (if not clearly postmenopausal).</li>
                    <li><a href="./postcoital-bleeding.html">Postcoital bleeding</a> (if bleeding only after sex).</li>
                    <li><a href="./symptomatic-colposcopy.html">Symptoms suggestive of cervical cancer (PCB/discharge) — referral &amp; colposcopy</a> (if cervix suspicious / symptoms suggest cervical cancer).</li>
                  </ul>
                </div>
              </div>

              <div class="callout ok">
                <strong>Key design decisions for the D&amp;G page</strong>
                <ul>
                  <li><strong>D&amp;G local process</strong>: PMB is managed via a <strong>parallel referral</strong> to <strong>TVUS</strong> and to <strong>gynaecology for clinic review regardless of ultrasound threshold</strong> (no explicit endometrial thickness cutoff stated in the local pathway).</li>
                  <li><strong>East vs West operational difference</strong> (at GP end):
                    <ul>
                      <li><strong>West</strong>: arrange <strong>TVUS first</strong> (as part of parallel referral) and patient is reviewed in clinic.</li>
                      <li><strong>East</strong>: refer to the clinic; gynaecology has access to USS in clinic (still parallel in effect).</li>
                    </ul>
                  </li>
                  <li><strong>Triage destinations</strong> (secondary care): recurrent PMB and people on tamoxifen may be seen directly in <strong>hysteroscopy clinic</strong>; suspected cervical cancer may be seen directly in <strong>colposcopy clinic</strong>. This depends on referral information.</li>
                </ul>
              </div>

              <h4>Comparator pathways (what differs elsewhere)</h4>
              <ul>
                <li>Many UK pathways use a <strong>TVUS endometrial thickness threshold</strong> to decide referral urgency (commonly <strong>5 mm</strong> in some services), and may discharge with safety‑netting if ET is below threshold and no focal lesion.</li>
                <li><strong>Example comparator (RefHelp Lothian)</strong>: states that with PMB, normal exam, and endometrial thickness &lt;5.0 mm (and no focal pathology), this may be managed without onward referral; if ET ≥5.0 mm, onward referral to gynaecology is required. This is presented here purely to highlight that D&amp;G appears to have chosen a <em>review‑regardless</em> model rather than a strict ET gate.</li>
              </ul>

              <div class="callout warn">
                <strong>Implication for the D&amp;G DGRefHelp page</strong>
                <ul>
                  <li>Make the local process explicit: <strong>parallel TVUS + gynae referral</strong> (no threshold gate) and highlight which clinic may receive the patient (general / hysteroscopy / colposcopy) depending on referral details.</li>
                  <li>Because triage tools/scores may be applied in secondary care, the DGRefHelp page should state <strong>the metrics the triaging team needs</strong> in the referral letter (see “Who to refer”).</li>
                </ul>
              </div>

              <div class="small">If you want, we can add a short “Why D&amp;G differs” paragraph once you confirm whether capacity/clinic model is the driver (e.g., one‑stop clinic vs radiology triage).</div>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="draft">

            <div class="callout" style="margin-bottom:12px">
              <strong>Copy/paste HTML for Right Decisions accordion sections</strong>
              <div class="small">These snippets contain section content only (no internal headings). Paste each into the matching accordion section.</div>
              <div style="height:10px"></div>
              <div class="copybar" style="justify-content:flex-start">
                <button class="btn" data-copy-target="#htmlBackground">Copy Background HTML</button>
                <button class="btn" data-copy-target="#htmlAssessment">Copy Assessment HTML</button>
                <button class="btn" data-copy-target="#htmlPCM">Copy Primary care mgmt HTML</button>
                <button class="btn" data-copy-target="#htmlRefer">Copy Who to refer HTML</button>
                <button class="btn" data-copy-target="#htmlNotRefer">Copy Who not to refer HTML</button>
                <button class="btn" data-copy-target="#htmlRefs">Copy References HTML</button>
              </div>

              <details style="margin-top:10px">
                <summary class="small" style="cursor:pointer">Show HTML snippets</summary>

                <h4 style="margin:12px 0 6px">Background (HTML)</h4>
                <pre id="htmlBackground">&lt;ul&gt;
  &lt;li&gt;Postmenopausal bleeding (PMB) = bleeding &amp;gt;12 months after last menstrual period (or any bleeding in someone who is established postmenopausal).&lt;/li&gt;
  &lt;li&gt;Main priority is to exclude malignancy (endometrial and cervical) while recognising common benign causes (atrophy, polyps, HRT-related bleeding).&lt;/li&gt;
  &lt;li&gt;D&amp;amp;G local process uses a &lt;strong&gt;parallel referral&lt;/strong&gt; model: &lt;strong&gt;TVUS&lt;/strong&gt; plus &lt;strong&gt;gynaecology review&lt;/strong&gt; (no stated endometrial thickness threshold gate).&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Assessment (primary care) (HTML)</h4>
                <pre id="htmlAssessment">&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;History:&lt;/strong&gt; onset, amount, recurrence/persistence; pain; discharge; postcoital bleeding; weight loss; anticoagulants; &lt;strong&gt;HRT&lt;/strong&gt; regimen and timing; &lt;strong&gt;tamoxifen&lt;/strong&gt;; cervical screening history (incl last test/result).&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Examination:&lt;/strong&gt; abdominal and speculum exam where appropriate; look for cervical lesion; bimanual if indicated.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Red flags / urgent same day:&lt;/strong&gt; haemodynamic compromise, severe pain, sepsis features, heavy ongoing bleeding not controlled.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Primary care management (HTML)</h4>
                <pre id="htmlPCM">&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Do not wait for symptoms to settle:&lt;/strong&gt; arrange referral per local pathway.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;D&amp;amp;G local process:&lt;/strong&gt; &lt;strong&gt;parallel referral&lt;/strong&gt; for &lt;strong&gt;transvaginal ultrasound (TVUS)&lt;/strong&gt; and &lt;strong&gt;gynaecology assessment&lt;/strong&gt; (patient reviewed regardless of ultrasound threshold).&lt;/li&gt;
  &lt;li&gt;If there is concern for cervical malignancy on speculum exam, make this explicit to enable colposcopy triage.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who to refer (HTML)</h4>
                <pre id="htmlRefer">&lt;p&gt;&lt;strong&gt;Refer all postmenopausal bleeding&lt;/strong&gt; via the local pathway, using the &lt;strong&gt;parallel referral&lt;/strong&gt; model (TVUS + gynaecology review).&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;East vs West (operational):&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;West:&lt;/strong&gt; arrange &lt;strong&gt;TVUS first&lt;/strong&gt; (as part of parallel referral) then clinic review.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;East:&lt;/strong&gt; refer to the clinic; gynaecology has access to USS in clinic.&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;strong&gt;Direct-to clinic triage (secondary care):&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Recurrent PMB&lt;/strong&gt; and/or &lt;strong&gt;on tamoxifen&lt;/strong&gt;: may be seen directly in &lt;strong&gt;hysteroscopy clinic&lt;/strong&gt; (same GP-end pathway; depends on referral detail).&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Suspicious cervical cancer&lt;/strong&gt; (abnormal cervix/visible lesion): may be seen directly in &lt;strong&gt;colposcopy clinic&lt;/strong&gt; (triage depends on referral detail).&lt;/li&gt;
&lt;/ul&gt;

&lt;p class=&quot;small&quot;&gt;&lt;strong&gt;Referral letter: required information (to support triage)&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;Bleeding pattern: single episode vs persistent vs &lt;strong&gt;recurrent&lt;/strong&gt; (dates, frequency).&lt;/li&gt;
  &lt;li&gt;HRT: none / sequential / continuous combined; any missed progestogen; any unscheduled bleeding context.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Tamoxifen&lt;/strong&gt; use (current/past).&lt;/li&gt;
  &lt;li&gt;Speculum findings: normal vs &lt;strong&gt;visible cervical lesion&lt;/strong&gt; / contact bleeding / suspicious features.&lt;/li&gt;
  &lt;li&gt;Cervical screening history (last test date/result; whether up to date).&lt;/li&gt;
  &lt;li&gt;Any anticoagulation and relevant comorbidities.&lt;/li&gt;
  &lt;li&gt;If available by the time of referral: TVUS outcome (endometrial thickness, focal lesion/polyp, adnexal findings).&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who not to refer (HTML)</h4>
                <pre id="htmlNotRefer">&lt;ul&gt;
  &lt;li&gt;In D&amp;amp;G, do not use an endometrial thickness threshold to avoid referral: the local model is parallel TVUS + review.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">References (HTML)</h4>
                <pre id="htmlRefs">&lt;ol&gt;
  &lt;li&gt;DGRefHelp D&amp;amp;G: Postmenopausal bleeding landing page (links to East/West pathways). https://www.rightdecisions.scot.nhs.uk/dgrefhelp-nhs-dumfries-galloway/womens-health/postmenopausal-bleeding/ (retrieved 2026‑02‑08)&lt;/li&gt;
  &lt;li&gt;RefHelp Lothian: Post Menopausal Bleeding (No HRT) (comparator pathway; ET threshold model). https://apps.nhslothian.scot/refhelp/guidelines/gynaecology/postmenopausalbleeding/ (retrieved 2026‑02‑08)&lt;/li&gt;
&lt;/ol&gt;</pre>
              </details>
            </div>

            <div id="draftText" class="section">
              <h3>Postmenopausal bleeding</h3>

              <div class="callout" style="margin:10px 0 12px">
                <strong>Related pages</strong>
                <div class="small">
                  <ul>
                    <li><a href="./bleeding-on-hrt.html">Bleeding on HRT</a></li>
                    <li><a href="./abnormal-uterine-bleeding.html">Abnormal uterine bleeding</a></li>
                    <li><a href="./postcoital-bleeding.html">Postcoital bleeding</a></li>
                    <li><a href="./symptomatic-colposcopy.html">Symptoms suggestive of cervical cancer (PCB/discharge) — referral &amp; colposcopy</a></li>
                  </ul>
                </div>
              </div>

              <h4>Background</h4>
              <ul>
                <li>Postmenopausal bleeding (PMB) = bleeding &gt;12 months after last menstrual period (or any bleeding in someone who is established postmenopausal).</li>
                <li>Main priority is to exclude malignancy (endometrial and cervical) while recognising common benign causes (atrophy, polyps, HRT-related bleeding).</li>
                <li><strong>D&amp;G local process:</strong> <strong>parallel referral</strong> model — <strong>TVUS</strong> plus <strong>gynaecology review</strong> (no stated endometrial thickness threshold gate).</li>
              </ul>

              <h4>Assessment (primary care) — collapsible</h4>
              <ul>
                <li><strong>History:</strong> onset, amount, recurrence/persistence; pain; discharge; postcoital bleeding; weight loss; anticoagulants; <strong>HRT</strong> regimen and timing; <strong>tamoxifen</strong>; cervical screening history (incl last test/result).</li>
                <li><strong>Examination:</strong> abdominal and speculum exam where appropriate; look for cervical lesion; bimanual if indicated.</li>
                <li><strong>Red flags / urgent same day:</strong> haemodynamic compromise, severe pain, sepsis features, heavy ongoing bleeding not controlled.</li>
              </ul>

              <h4>Primary care management</h4>
              <ul>
                <li><strong>Do not wait for symptoms to settle:</strong> arrange referral per local pathway.</li>
                <li><strong>D&amp;G local process:</strong> make a <strong>parallel referral</strong> for <strong>TVUS</strong> and <strong>gynaecology assessment</strong> (patient reviewed regardless of ultrasound threshold).</li>
                <li>If there is concern for cervical malignancy on speculum exam, make this explicit to enable colposcopy triage.</li>
              </ul>

              <h4>Who to refer</h4>
              <p class="small">Key principle: the referral letter content affects triage (general clinic vs hysteroscopy clinic vs colposcopy clinic). Include the metrics secondary care needs.</p>

              <h4>All PMB (local pathway)</h4>
              <ul>
                <li><strong>Refer all PMB</strong> via the local pathway, using the <strong>parallel referral</strong> model (TVUS + gynaecology review).</li>
              </ul>

              <h4>East vs West (operational)</h4>
              <ul>
                <li><strong>West:</strong> arrange <strong>TVUS first</strong> (as part of parallel referral) then clinic review.</li>
                <li><strong>East:</strong> refer to the clinic; gynaecology has access to USS in clinic.</li>
              </ul>

              <h4>May be triaged directly (secondary care)</h4>
              <ul>
                <li><strong>Recurrent PMB</strong> and/or <strong>on tamoxifen</strong>: may be seen directly in <strong>hysteroscopy clinic</strong> (same GP-end pathway; depends on referral detail).</li>
                <li><strong>Suspicious cervical cancer</strong> (abnormal cervix/visible lesion): may be seen directly in <strong>colposcopy clinic</strong> (triage depends on referral detail).</li>
              </ul>

              <h4>Referral letter: required information (triage metrics)</h4>
              <ul>
                <li>Bleeding pattern: single episode vs persistent vs <strong>recurrent</strong> (dates, frequency).</li>
                <li>HRT: none / sequential / continuous combined; any missed progestogen; any unscheduled bleeding context.</li>
                <li><strong>Tamoxifen</strong> use (current/past).</li>
                <li>Speculum findings: normal vs <strong>visible cervical lesion</strong> / contact bleeding / suspicious features.</li>
                <li>Cervical screening history (last test date/result; whether up to date).</li>
                <li>Any anticoagulation and relevant comorbidities.</li>
                <li>If available by the time of referral: TVUS outcome (endometrial thickness, focal lesion/polyp, adnexal findings).</li>
              </ul>

              <h4>Who not to refer</h4>
              <ul>
                <li>In D&amp;G, do not use an endometrial thickness threshold to avoid referral: the local model is parallel TVUS + review.</li>
              </ul>

              <h4>Local agreement needed (drafting-site only)</h4>
              <ul>
                <li><label><input type="checkbox" disabled /> Confirm the exact referral routes in SCI Gateway for East vs West (wording, destination clinic names).</label></li>
                <li><label><input type="checkbox" disabled /> Confirm whether there are any explicit urgency categories (e.g., “urgent suspected cancer” vs “urgent”) applied at the GP end, or whether this is entirely triaged within gynae.</label></li>
                <li><label><input type="checkbox" disabled /> Confirm whether any additional mandatory investigations are expected before referral in D&amp;G (e.g., pregnancy test if perimenopausal uncertainty, swabs if discharge etc.).</label></li>
              </ul>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="refs">
            <div class="section">
              <h3>References</h3>
              <ol>
                <li>DGRefHelp D&amp;G: Postmenopausal bleeding landing page (links to East/West pathways). <a href="https://www.rightdecisions.scot.nhs.uk/dgrefhelp-nhs-dumfries-galloway/womens-health/postmenopausal-bleeding/">https://www.rightdecisions.scot.nhs.uk/dgrefhelp-nhs-dumfries-galloway/womens-health/postmenopausal-bleeding/</a> (retrieved 2026‑02‑08)</li>
                <li>RefHelp Lothian: Post Menopausal Bleeding (No HRT) (comparator pathway; ET threshold model). <a href="https://apps.nhslothian.scot/refhelp/guidelines/gynaecology/postmenopausalbleeding/">https://apps.nhslothian.scot/refhelp/guidelines/gynaecology/postmenopausalbleeding/</a> (retrieved 2026‑02‑08)</li>
              </ol>
              <div class="small">If you want a NICE/SIGN/BGCS citation block here, I’ll add it once we agree which national guidance set you want to anchor PMB to (Scotland often uses Scottish Cancer Referral Guidelines rather than NICE NG12 wording).</div>
            </div>
          </div>

        </div>
      </div>
    </div>
  </div>

  <script src="../assets/site.js"></script>
</body>
</html>
